MoneyWorks4Me

Shilpa Medicare informs about company updates

09 Mar 2017 Evaluate

Shilpa Medicare has informed that given the strong performance of the Company, the Board has authorized the Managing Director, Vishnukant C. Bhutada to identify and evaluate further opportunities and ideas for organic and inorganic growth including acquisitions in similar and adjacent businesses.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..